Patients With Hepatocellular Carcinoma (HCC) | MicrobiomeTrials← Back to trialsNCT07690683
Patients With Hepatocellular Carcinoma (HCC)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2028-09
Enrollment target: 52 participants Locations- Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli,, Roma, Italy
Other microbiome trials you might be interested in
Post-Hepatectomy Liver FailureLiver FailureLiver NeoplasmsCarcinoma, HepatocellularLiver MetastasesPostoperative ComplicationsHepatic Congestion
Removing a large part of the liver (major hepatectomy) can cure primary and secondary liver cancers, but it carries the …
Minya, EgyptEst. completion Apr 30, 2028
Cancer Harboring BRAF AlterationsHGGLGG
Solid Tumors
The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF a…
Beverly Hills, United StatesEst. completion Dec 31, 2027
Hepatocellular Carcinoma (HCC)
The goal of this interventional study (clinical trial) is to evaluate the efficacy and safety of adding dapagliflozin to…
Multiple LocationsEst. completion Jul 2029